Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $112,265 - $131,705
1,181 New
1,181 $129,000
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $288,812 - $352,188
-2,533 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.04%
2,533 $356,000
Q3 2021

Oct 28, 2021

SELL
$116.66 - $129.06 $13,649 - $15,100
-117 Reduced 4.42%
2,532 $299,000
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $51,202 - $60,272
-484 Reduced 15.45%
2,649 $307,000
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $10,557 - $12,438
-97 Reduced 3.0%
3,133 $375,000
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $157,395 - $171,515
-1,499 Reduced 31.7%
3,230 $354,000
Q3 2020

Oct 23, 2020

BUY
$91.64 - $111.29 $137,551 - $167,046
1,501 Added 46.5%
4,729 $515,000
Q2 2020

Jul 31, 2020

SELL
$76.57 - $98.0 $46,860 - $59,976
-612 Reduced 15.94%
3,228 $295,000
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $57,605 - $84,235
917 Added 31.37%
3,840 $303,000
Q4 2019

Jan 23, 2020

BUY
$78.51 - $87.4 $78 - $87
1 Added 0.03%
2,923 $254,000
Q3 2019

Oct 29, 2019

BUY
$81.84 - $88.74 $81 - $88
1 Added 0.03%
2,922 $245,000
Q2 2019

Aug 02, 2019

SELL
$72.88 - $85.0 $79,657 - $92,905
-1,093 Reduced 27.23%
2,921 $246,000
Q1 2019

May 01, 2019

SELL
$66.22 - $80.06 $78,536 - $94,951
-1,186 Reduced 22.81%
4,014 $321,000
Q4 2018

Feb 04, 2019

BUY
$65.56 - $74.27 $340,912 - $386,204
5,200 New
5,200 $376,000
Q3 2018

Oct 26, 2018

SELL
$60.81 - $73.36 $316,090 - $381,325
-5,198 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$57.57 - $63.54 $115 - $127
2 Added 0.04%
5,198 $317,000
Q1 2018

May 04, 2018

BUY
$56.27 - $63.62 $56 - $63
1 Added 0.02%
5,196 $311,000
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $278,867 - $298,556
5,195
5,195 $296,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Advanced Asset Management Advisors Inc Portfolio

Follow Advanced Asset Management Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.